IS NOW APPROVED IN BRAZIL
SOPHIA ANTIPOLIS, France, and LAVAL, Quebec, April 16, 2021 – Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”), Bausch + Lomb, its leading global eye health business, and Nicox (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced that VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, has received regulatory approval from the Brazilian Health Regulatory Agency (ANVISA – Agência Nacional de Vigilância Sanitária).
VYZULTA is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension in the United States and other territories that have the same indication.
1
“The approval of VYZULTA in Brazil marks its tenth regulatory approval. We will continue to focus our efforts on securing additional regulatory approvals for this important treatment option for people suffering from glaucoma to help address this
Bausch Health Companies Inc. Bausch + Lomb, its leading global eye health business, and Nicox an international ophthalmology company, today announced that VYZULTA® 0.024%, has received regulatory approval from the Brazilian Health Regulatory Agency . VYZULTA is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension in the United States and other .
The
Athlete’s Foot Drugs Market report includes dynamics of the market as well which enhances the growth of the industry. The report is made after a robust methodology which includes primary and secondary research work, interviews with top key players of the market, and consumer surveys which helps to forecast the upcoming opportunities. The Athlete’s Foot Drugs Market report provides the anticipated behavior of the market and the changing market scenario which can influence the performance of the industry over the forecasted period 2020-2027. The report is segmented and sub-segmented into various domains which shows the impact of different factors in the industry.
New Report Reveals That More Than One-Third Of IBS Patients Surveyed State It Has Been More Challenging To Manage Their Symptoms During The COVID-19 Pandemic yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
PharmiWeb.com is Europe s leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. follow us Version: 2021.4.7.1
You are leaving PharmiWeb.com
Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites.